Fund details
Invests in startups born from science projects, applying a thesis-driven approach to realize their full commercial potential.
Go to profile
Partners related to this fund
Shelby Newsad
Investor
Shelby is an investor at Compound with a focus on biology and healthcare. She holds an undergraduate degree in biochemistry, an MPhil in bioscience enterprise, and is awaiting her Ph.D. defense in plant sciences from the University of Cambridge. Shelby’s research spans neuroscience, drug discovery, and plant sciences. She has also interned at Merck KGaA and worked with European VC firms like Hummingbird Ventures and Ahren Innovation Capital.
Investor scope
Investment criteria breakdown.
Investment stages
Seed
Series A
Target regions
USA
Europe
Investment ranges
$100K - $500K
$500K - $1M
$1M - $3M
Focus areas
Biotech
Web3
Deeptech
Enterprise
AI
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.
Related Sector Funds
Funds investing in similar sectors.
.svg)
